AU2003236207A1 - The hydrochloride of (s)-(+)-3-(1-(2-(1-acetyl-2,3-dihydro-1h-indol-3-yl)ethyl)-1,2,3,6-tetrahydropyridin-4-yl)-6-chloro-1h-indole - Google Patents

The hydrochloride of (s)-(+)-3-(1-(2-(1-acetyl-2,3-dihydro-1h-indol-3-yl)ethyl)-1,2,3,6-tetrahydropyridin-4-yl)-6-chloro-1h-indole

Info

Publication number
AU2003236207A1
AU2003236207A1 AU2003236207A AU2003236207A AU2003236207A1 AU 2003236207 A1 AU2003236207 A1 AU 2003236207A1 AU 2003236207 A AU2003236207 A AU 2003236207A AU 2003236207 A AU2003236207 A AU 2003236207A AU 2003236207 A1 AU2003236207 A1 AU 2003236207A1
Authority
AU
Australia
Prior art keywords
tetrahydropyridin
indol
indole
dihydro
acetyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003236207A
Other versions
AU2003236207A8 (en
Inventor
Benny Bang-Andersen
Heidi Lopez De Diego
Gitte Ludvig
Ole Nielsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
H Lundbeck AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck AS filed Critical H Lundbeck AS
Publication of AU2003236207A1 publication Critical patent/AU2003236207A1/en
Publication of AU2003236207A8 publication Critical patent/AU2003236207A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
AU2003236207A 2002-05-31 2003-05-22 The hydrochloride of (s)-(+)-3-(1-(2-(1-acetyl-2,3-dihydro-1h-indol-3-yl)ethyl)-1,2,3,6-tetrahydropyridin-4-yl)-6-chloro-1h-indole Abandoned AU2003236207A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US38446602P 2002-05-31 2002-05-31
DKPA200200843 2002-05-31
DKPA200200843 2002-05-31
US60/384,466 2002-05-31
PCT/DK2003/000341 WO2003102097A1 (en) 2002-05-31 2003-05-22 The hydrochloride of (s)-(+)-3-[1-[2-(1-acetyl-2,3-dihydro-1h-indol-3-yl)ethyl]-1,2,3,6-tetrahydropyridin-4-yl]-6-chloro-1h-indole

Publications (2)

Publication Number Publication Date
AU2003236207A1 true AU2003236207A1 (en) 2003-12-19
AU2003236207A8 AU2003236207A8 (en) 2003-12-19

Family

ID=29713303

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003236207A Abandoned AU2003236207A1 (en) 2002-05-31 2003-05-22 The hydrochloride of (s)-(+)-3-(1-(2-(1-acetyl-2,3-dihydro-1h-indol-3-yl)ethyl)-1,2,3,6-tetrahydropyridin-4-yl)-6-chloro-1h-indole

Country Status (2)

Country Link
AU (1) AU2003236207A1 (en)
WO (1) WO2003102097A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023201421A1 (en) * 2022-04-19 2023-10-26 Mindset Pharma Inc. Indoline derivatives as serotonergic agents useful for the treatment of disorders related thereto

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA9711376B (en) * 1996-12-20 1998-07-21 Lundbeck & Co As H Indole or dihydroindole derivatives
AR028685A1 (en) * 2000-06-14 2003-05-21 Lundbeck & Co As H INDOL DERIVATIVES
AR033287A1 (en) * 2001-05-09 2003-12-10 Lundbeck & Co As H ADHD TREATMENT

Also Published As

Publication number Publication date
WO2003102097A8 (en) 2004-12-29
WO2003102097A1 (en) 2003-12-11
AU2003236207A8 (en) 2003-12-19

Similar Documents

Publication Publication Date Title
AU2001263399A1 (en) 1-(pyrrlolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indo linone derivatives
HK1059621A1 (en) 3-(4-Amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
AU2002303892A1 (en) 5-aralkylsulfonyl-3- (pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors
HK1080843A1 (en) (3z)-3-(3-hydro-isobenzofuran-1-ylidene)-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
EP1828143A4 (en) 2-(phenyl or heterocyclic)-1h-phenantrho[9,10-d]imidazoles as mpges-1 inhibitors
AU2003265681A1 (en) Indoles having anti-diabetic activity
AU2003211425A1 (en) Semiconductor storage
AU2003245555A1 (en) Sphingosine kinase inhibitors
AU2003271074A1 (en) Semiconductor storage
AU2003255767A1 (en) 3-(carbonyl) 1h-indazole compounds as cyclin dependent kinases (cdk) inhibitors
AU2003274307A1 (en) 5-ht 1b/1d receptor agonists for the treatment of headache resulting from administering an endothelin receptor antagonist
AU2003290059A1 (en) Use of cd137 antagonists for the treatment of tumors
AU2003212310A1 (en) (4,2-disubstituted-thiazol-5-yl)amine compounds as pde7 inhibitors
AU2003239508A1 (en) Indole compounds useful as impdh inhibitors
AU2003217264A1 (en) Holder for storage boxes
AU2003236207A1 (en) The hydrochloride of (s)-(+)-3-(1-(2-(1-acetyl-2,3-dihydro-1h-indol-3-yl)ethyl)-1,2,3,6-tetrahydropyridin-4-yl)-6-chloro-1h-indole
AU2003206395A1 (en) Media holding package
AU2003280578A1 (en) Heterocyclic compounds
IL155706A0 (en) Process for the preparation of (r)-5-(2-benzenesulfonylethyl)-3-(n-methylpyrrolidin-2-ylmethyl)-1h-indole
MX252778B (en) Crystal modification ii of 2-[2-(1 -chloro- cyclopropyl)-3 -(2-chlorophenyl)- 2-hydroxy -propyl]-2, 4-dihydro -3h-1, 2, 4-triazole -3-thions.
AU3476599A (en) Indol-3-yl-cyclohexyl amine derivatives for the treatment of depression (5-ht1 receptor antagonists)
AU2003243930A1 (en) Pharmaceutical composition comprising (s)-(+)-3-(1-(2-(1-acetyl-2,3-dihydro-1h-indol-3-yl)ethyl)-1,2,3,6-tetrahydropyridin-4-yl)-6-chloro-1h-indole
AU2003222435A1 (en) Process for the preparation of 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)- 1,3-dihydro-5-isobenzofuran carbonitrile
AU2003257407A1 (en) S-(+)-3-{1-(2-(2,3-dihydro-1h-indol-3-yl)ethyl)-3,6-dihydro-2h-pyridin-4-yl}-6-chloro-1h-indole and acid addition salts thereof
AU2003222399A1 (en) Process for the synthesis of base addition salts of 2,3-0-isopropylidene-1-0-substituted-5,6-dideoxy-5-n- (4-(2-hydroxy-2-oxoethyl)-phenylaminocarbonyl) amino-l-gulofuranosides

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase